Physician profile
Ashim Ahuja
NPI 1972063329
$51,288.16
in general payments reported to CMS, 2019-2025
17 companies · $380 in 2025
The $380 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $156 · 2023: $30K · 2024: $21K · 2025: $380.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $49K · Food and Beverage: $1,887 · Education: $154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $49,091.00 |
| Food and Beverage | $1,887.19 |
| Education | $154.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $30,000.00 | 2023-2024 | Activa Pc |
| Boston Scientific Corporation | $10,074.96 | 2023-2024 | Vercise |
| Abbott Laboratories | $9,091.00 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $390.19 | 2023-2025 | Austedo Xr, Ajovy |
| Alexion Pharmaceuticals, INC. | $231.56 | 2023-2024 | Soliris |
| Acorda Therapeutics, INC | $227.60 | 2022-2023 | Inbrija |
| Livanova USA, INC. | $222.13 | 2023 | Vns Therapy Sentiva Model 1000 Generator |
| Alnylam Pharmaceuticals INC. | $143.70 | 2025 | Amvuttra |
| Insightec,INC | $141.34 | 2024 | Exablate |
| Grifols USA, LLC | $131.47 | 2023 | Gamunex-C |
| Eisai INC. | $125.00 | 2025 | |
| Novartis Pharmaceuticals Corporation | $116.66 | 2024 | |
| Genzyme Corporation | $111.93 | 2023 | |
| Biogen, INC. | $108.50 | 2023 | Vumerity |
| Ucb, INC. | $81.91 | 2022-2023 | Nayzilam |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $56.78 | 2024-2025 | |
| Sk Life Science, INC. | $33.43 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashim Ahuja listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.